"Once the full data set has been obtained, Relief will reach out to European regulators to present the outcomes of the Phase 2b/3 clinical trial. A European Phase 2b/3 clinical trial is planned to be initiated later this year".
Pretty weak PR...Why not claim application for EU approvals. A COVID Trial in the EU does not make much sense with Trials of Inhaler and IV formulations tested against COVID already. Makes more sense for a Lung Long-hauler's treatment Clinical Trial of some sort, ASAP.